ArticleScientific reports2020

In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation.

Rosemarie Krupar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.